Company / Total Assets
Mereo BioPharma Group plc Total Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$45.9M
FY2025
5-year range
$45.9M / $76.4M
FY2023-FY2025
Trend
-39.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $66M to $46M over the past 2 years.
Based on SEC 10-K filings.
$46M in FY2025.
Declined from $66M to $46M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, total assets decreased 39.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.9M | -39.9% |
| FY2024 | $76.4M | +14.9% |
| FY2023 | $66.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 27, 2026